Table 1. Basal levels of selected ISGs were down-regulated in human lung cancer cell lines compared to Beas2B cells.

	CRL5800	CRL5807	CRL5810	CRL5872	HTB182	CRL5928	CRL5869
TLR3	−36.00	−31.34	−23.43	−21.41	−2.89	−1.39	1.47
IFNα	−7.01	−7.46	−4.53	−5.89	−5.54	−1.17	4.06
IFNβ	−35.75	−19.03	−15.35	−4.11	−5.90	1.67	1.11
IRF5	−1.87	−8.46	−3.86	−2.57	−1.01	−2.03	1.80
IRF7	−22.32	−6.73	−25.99	−66.26	−4.53	−13.36	−4.79
IRF8	2.27	−1.02	−1.65	4.86	−1.69	30.27	47.18
Stat1	−12.55	−15.24	−6.54	−32.45	−1.87	−2.25	−2.38
OAS1	−19.16	−9.06	−92.41	7.94	−4.53	−1.96	2.01
IFI15	−143.01	−20.97	−519.15	−270.60	−28.64	−24.76	−77.71
IFI78	−109.90	−7.57	−232.32	−12.38	1.60	−16.91	−2.60
IFNAR1	−4.35	−2.91	1.20	−7.11	−1.66	−6.15	−1.10
IRF3	−13.36	−20.97	−36.76	−7.31	−21.26	−7.21	1.44
IFI16	−112.99	−2.95	−308.69	−55.33	−52.71	−172.45	−9.45
IFI27	−26.91	−2592.27	−436.55	−6.36	−689.78	−2.43	−27.86